BioSpace News Archive

BioMidwest

Omron Healthcare Named a 2019 Winner of Chicago’s “Best and Brightest Companies to Work For”

Award by National Association for Business Resources recognizes innovative organizations that are leading their industries and contributing to society

June 26, 2019
·
3 min read
Drug Development

InDex Pharmaceuticals Enrolls Last Patient in Phase IIb Study CONDUCT With Cobitolimod

InDex Pharmaceuticals Holding AB announced that patient enrolment was completed in the dose optimisation study CONDUCT, which is evaluating cobitolimod for the treatment of moderate to severe ulcerative colitis.

June 26, 2019
·
5 min read
Policy

/R E P E A T -- Notice to the media - Minister of Health to announce support to promote mental health for Black Canadians/

The Honourable Ginette Petitpas Taylor, Federal Minister of Health, will announce Government of Canada funding towards programs that support mental health within Black Canadian communities.

June 26, 2019
·
1 min read
FDA

U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure

The U.S. Food and Drug Administration has granted Fast Track designation to empagliflozin for the reduction of the risk of cardiovascular death and hospitalization for heart failure in people with chronic heart failure, Boehringer Ingelheim and Eli Lilly and Company announced.

June 26, 2019
·
14 min read
Lilly’s AWARD-11 trial studying higher investigational doses of Trulicity® (dulaglutide) demonstrated superiority in A1C reduction in people with type 2 diabetes

Eli Lilly and Company’s trial studying higher investigational doses of Trulicity® met its primary efficacy endpoint of superiority, significantly reducing A1C from baseline in people with type 2 diabetes, compared to once-weekly Trulicity 1.5 mg after 36 weeks.

June 26, 2019
·
9 min read
Deals

Omada Health Raises $73 Million to Accelerate Program Expansion

Digital Care Leader’s Integrated Program Supports Individuals Dealing with Chronic Disease, Mental Health Issues

June 26, 2019
·
3 min read
Business

Decibel Therapeutics Appoints Healthcare Industry Veteran Christine A. Poon to its Board of Directors

Decibel Therapeutics, a clinical-stage biotechnology company developing novel therapeutics for hearing loss and balance disorders, announced the appointment of Christine Poon to its board of directors.

June 26, 2019
·
2 min read
Drug Development

MDNA55 Shows Promising Results in Models of Ovarian Cancer

Scientists at the NIH and FDA Demonstrate Impressive Synergy of MDNA55 with Interferons

June 26, 2019
·
5 min read
Drug Development

Minovia Announces Dosing of Patient in First Mitochondrial Cell Therapy Trial for the Treatment of Pearson Syndrome

Minovia Therapeutics announced dosing of the first patient in a Phase I/II clinical trial of the company’s Mitochondrial Augmentation Therapy for the treatment of Pearson syndrome.

June 26, 2019
·
6 min read
Biotech Bay

Celltrion Adopts Veeva Vault eTMF for Greater Visibility into Trial Activities

Leading South Korean biopharmaceutical modernizes trial operations to maintain inspection readiness and have a comprehensive view of study status

June 26, 2019
·
4 min read